trending Market Intelligence /marketintelligence/en/news-insights/trending/kgiuomra0uo51cxmfekd6q2 content esgSubNav
In This List

SIGA Technologies to relist on Nasdaq

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


SIGA Technologies to relist on Nasdaq

New York-based SIGA Technologies, Inc. said it will relist on the Nasdaq Global Market on March 22.

The company's stock will trade under the SIGA ticker symbol.

SIGA Technologies is the developer of oral Tpoxx, also known as tecovirimat, to treat smallpox. The treatment is being reviewed by the U.S. Food and Drug Administration for approval.